111 related articles for article (PubMed ID: 626717)
41. CD8+ CD56+ mycosis fungoides with an indolent clinical behaviour: case report and literature review.
Sawada Y; Sugita K; Kabashima R; Hino R; Nakamura M; Koga C; Tokura Y
Acta Derm Venereol; 2010 Sep; 90(5):525-6. PubMed ID: 20814634
[No Abstract] [Full Text] [Related]
42. Thy-1 and T-cell receptor antigen expression in mycosis fungoides and benign inflammatory dermatoses.
Fivenson DP; Rheins LA; Nordlund JJ; Pomaranski M; Douglass MC; Krull EA
J Natl Cancer Inst; 1991 Aug; 83(15):1088-92. PubMed ID: 1678789
[TBL] [Abstract][Full Text] [Related]
43. Selective immunological evaluation of mycosis fungoides.
Cooperrider PA; Roenigk HH
Arch Dermatol; 1978 Feb; 114(2):207-12. PubMed ID: 629547
[TBL] [Abstract][Full Text] [Related]
44. Anti-Ia-reactive cells in mycosis fungoides: a study of skin biopsies, single epidermal cells and circulating T lymphocytes.
Tjernlund UM; Scheynius A; Kabelitz D; Klareskog L
Acta Derm Venereol; 1981; 61(4):291-301. PubMed ID: 6173983
[TBL] [Abstract][Full Text] [Related]
45. Pediatric CD8+/CD56+ mycosis fungoides with cytotoxic marker expression: A variant with indolent course.
Rovaris M; Colato C; Girolomoni G
J Cutan Pathol; 2018 Oct; 45(10):782-785. PubMed ID: 29968317
[TBL] [Abstract][Full Text] [Related]
46. The pathogenesis of mycosis fungoides.
Girardi M; Heald PW; Wilson LD
N Engl J Med; 2004 May; 350(19):1978-88. PubMed ID: 15128898
[No Abstract] [Full Text] [Related]
47. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.
Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
J Am Acad Dermatol; 2014 Feb; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969
[TBL] [Abstract][Full Text] [Related]
48. Immunocytological characterization of the mycosis fungoides tumour cell.
Claudy AL; Schmitt D; Alario A; Brochier J; Perrot H; Thivolet J
Bull Cancer; 1977; 64(2):241-8. PubMed ID: 303133
[TBL] [Abstract][Full Text] [Related]
49. An erythematous plaque on the neck. Folliculotropic mycosis fungoides (MF), stage IVA(T1N3M0).
Lee JW; Kim DH; Park KY; Han TY; Li K; Seo SJ; Hong CK; Cho KH
Clin Exp Dermatol; 2011 Aug; 36(6):685-7. PubMed ID: 21771016
[No Abstract] [Full Text] [Related]
50. Folliculotropic mycosis fungoides with central nervous system involvement: demonstration of tumor clonality in intrafollicular T cells using laser capture microdissection.
Ke MS; Kamath NV; Nihal M; Mikkola DL; Koc ON; Stevens SR; Gilliam AC; Cooper KD; Wood GS
J Am Acad Dermatol; 2003 Feb; 48(2):238-43. PubMed ID: 12582395
[TBL] [Abstract][Full Text] [Related]
51. Expression of the CD4+ cell-specific chemoattractant interleukin-16 in mycosis fungoides.
Blaschke V; Reich K; Middel P; Letschert M; Sachse F; Harwix S; Neumann C
J Invest Dermatol; 1999 Oct; 113(4):658-63. PubMed ID: 10504456
[TBL] [Abstract][Full Text] [Related]
52. T and B cells and cell-mediated immunity in mycosis fungoides.
Nordqvist BC; Kinney JP
Cancer; 1976 Feb; 37(2):714-8. PubMed ID: 130203
[TBL] [Abstract][Full Text] [Related]
53. Decreased expression of fas (APO-1/CD95) on lesional CD4+ T lymphocytes in cutaneous T cell lymphomas: correlations with blood data.
Dereure O; Portales P; Clot J; Guilhou JJ
Br J Dermatol; 2001 Dec; 145(6):1031-2. PubMed ID: 11899134
[No Abstract] [Full Text] [Related]
54. Analysis of V(H) genes rearranged by individual B cells in dermal infiltrates of patients with mycosis fungoides.
Förste N; Gellrich S; Golembowski S; Rutz S; Audring H; Sterry W; Jahn S
Clin Exp Immunol; 1997 Dec; 110(3):464-71. PubMed ID: 9409652
[TBL] [Abstract][Full Text] [Related]
55. Immunophenotypic shift from CD4(+) to CD8(+) in mycosis fungoides.
Endo C; Naka Y; Miyagaki T; Fujita H; Sugaya M; Kawashima M; Tsunemi Y
Br J Dermatol; 2016 Oct; 175(4):830-3. PubMed ID: 27167533
[No Abstract] [Full Text] [Related]
56. Soluble IL2 receptor serum levels and epidermal cytokines in mycosis fungoides and related disorders.
Zachariae C; Larsen CS; Kaltoft K; Deleuran B; Larsen CG; Thestrup-Pedersen K
Acta Derm Venereol; 1991; 71(6):465-70. PubMed ID: 1685826
[TBL] [Abstract][Full Text] [Related]
57. Defective monocyte chemotaxis in mycosis fungoides.
Seitz LE; Golitz LE; Weston WL; Aeling JE; Dustin RD
Arch Dermatol; 1977 Aug; 113(8):1055-7. PubMed ID: 329770
[TBL] [Abstract][Full Text] [Related]
58. Successfully treated Hodgkin's disease followed by mycosis fungoides: case report and review of the literature.
Kaufman D; Gordon LI; Variakojis D; Caro WA; Marder R; Jumbelic M; Roenigk HH
Cutis; 1987 Apr; 39(4):291-6. PubMed ID: 3581901
[TBL] [Abstract][Full Text] [Related]
59. The current state and future of clonality studies in mycosis fungoides.
Jones D; Duvic M
J Invest Dermatol; 2003 Sep; 121(3):ix-x. PubMed ID: 12925230
[No Abstract] [Full Text] [Related]
60. A case of rapidly progressive, fatal mycosis fungoides presenting as a haematoma-like lesion.
Hattori T; Uchiyama A; Tago O; Nagai Y; Ishikawa O
Acta Derm Venereol; 2013 Nov; 93(6):707-10. PubMed ID: 23493993
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
